Effects of other deprivation

ST19_EFFEC_OTHER_DEPRI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T73 Cause of death: ICD-10 — T73 2 out of 7 registries used, show all original rules.	95
4. Check minimum number of events None	95
5. Include endpoints None	95
6. Filter based on genotype QC (FinnGen only)	91

Control definitions (FinnGen only)

Control exclude: ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T6[6-9]|T7[0-8]
Name in latin: Effectus aliarum privationum

NAME	ST19_EFFEC_OTHER_DEPRI
CONTROL_EXCLUDE	ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T73
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T73
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Effects of other deprivation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	91	57	34
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	37.21	40.57	31.57

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
95: Matched controls
950

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

T73.3

ICD-10 Finland

Exhaustion due to excessive exertion

2821.3

90.5

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.4

8.2

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

19.6

6.4

T73.0

ICD-10 Finland

Effects of hunger

+∞

6.3

T73.9

ICD-10 Finland

Effect of deprivation, unspecified

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

167

2.16

2.85

1.7

1.9

0.72

1.10

mg/l

0.70

120

(3003396) Base excess in Arterial blood by calculation

2.67

2.81

2.1

7.2

0.66

1.55

mmol/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

4.03

2.75

1.8

1.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

258

1.95

2.51

4.7

3.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2.51

2.39

2.1

7.1

4.81

5.00

kpa

0.51

(3027801) Oxygen [Partial pressure] in Arterial blood

2.51

2.39

2.1

7.1

13.84

12.88

kpa

0.25

(40760892) CBC W Ordered Manual Differential panel - Blood

363

1.87

2.33

5.5

6.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

3.70

2.33

1.8

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2.52

2.27

1.0

1.4

34.80

160.57

iu/ml

—

(3027008) Opiates [Presence] in Urine

2.53

2.16

2.0

1.6

—

(3027944) Amphetamines [Presence] in Urine

2.53

2.16

2.0

1.6

—

(3028300) Cannabinoids [Presence] in Urine

2.53

2.16

2.0

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

105

2.15

2.16

1.3

1.5

256.00

585.00

titre

—

(3000764) Benzodiazepines [Presence] in Urine

2.48

2.08

2.0

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

392

1.80

2.06

6.7

5.7

1.85

1.90

e9/l

0.18

361

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

146

1.97

2.04

1.4

1.3

0.93

8.29

u/ml

—

(3016879) Cocaine [Presence] in Urine

2.40

1.82

2.1

1.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

293

1.70

1.71

8.9

4.8

37.75

36.63

g/l

0.62

281

(3001604) Monocytes [#/volume] in Blood

378

1.68

1.69

6.9

5.6

0.58

0.56

e9/l

0.19

344

(3052851) Hemolysis interference index of Serum or Plasma

3.30

1.69

2.0

2.1

—

(3000991) Gas panel - Venous blood

2.36

1.64

5.8

7.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

3.71

1.63

2.0

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

125

1.87

1.60

4.9

2.4

25.82

3.27

e6/l

—

(3023368) Bacteria identified in Blood by Culture

184

1.74

1.56

3.3

4.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

1.56

0.0

1.3

—

(3021589) Normoblasts [#/volume] in Blood

327

1.64

1.55

7.4

8.8

0.00

0.01

e9/l

0.50

270

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

3.46

1.54

4.0

2.5

242.80

274.40

pmol/l

—

(3006315) Basophils [#/volume] in Blood

378

1.61

1.47

7.0

5.6

0.04

e9/l

0.14

344

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2.84

1.46

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.31

1.45

2.3

1.6

—

(3011288) Drugs identified in Urine by Screen method

2.32

1.41

2.3

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2.02

1.36

4.7

2.2

394.23

361.94

nmol/l

0.27

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

0.00

1.35

0.0

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.47

1.33

2.3

7.4

—

(3002582) Erythrocytes [#/volume] in Urine

228

1.61

1.30

5.3

2.8

20.17

59.29

e6/l

0.74

174

(3012544) pH of Venous blood

2.04

1.29

6.0

3.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

134

1.73

1.28

3.9

3.1

18.67

139.79

ng/l

1.57

(3021601) Nitrite [Presence] in Urine by Test strip

368

1.55

1.27

5.6

4.7

0.00

estimate

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

194

1.63

1.27

1.3

0.71

1.42

u/ml

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2.49

1.26

2.7

1.5

0.20

0.24

g/l

—

(3013707) Erythrocyte sedimentation rate by Westergren method

580

1.61

1.25

3.7

3.8

8.26

10.31

mm/h

1.00

537

(3037467) Urinalysis macro (dipstick) panel - Urine

519

1.56

1.22

5.7

4.0

—

(40758558) Short blood count panel - Blood

180

1.61

1.17

12.4

8.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.09

1.15

1.8

1.1

—

(3018418) pH of Serum or Plasma

200

1.57

1.11

8.8

4.1

7.39

7.40

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.28

1.10

1.3

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

2.45

1.10

1.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.81

1.08

2.1

6.1

103.79

104.51

mmol/l

0.27

(3048689) Calprotectin [Mass/mass] in Stool

1.74

1.08

1.7

2.0

56.90

87.29

ug/g

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

256

1.51

1.06

3.3

3.1

13.85

38.61

ng/l

1.38

142

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.99

1.06

1.4

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

134

1.62

1.02

1.8

2.3

—

(4200892) Spirometry reversibility

1.88

1.00

1.6

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

0.00

0.99

0.0

3.6

—

301.87

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

441

1.46

0.99

11.1

11.2

3.80

4.19

e9/l

0.79

397

(3009261) Glucose [Presence] in Urine by Test strip

373

1.45

0.98

4.3

3.2

0.00

estimate

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.96

0.96

1.7

8.9

0.66

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.96

0.96

1.7

8.9

1.34

1.31

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2.30

0.95

2.7

1.8

41.67

36.22

nmol/l

—

(3030467) Casts [#/volume] in Urine by Automated count

207

1.50

0.94

4.2

2.8

0.11

0.25

e6/l

0.72

153

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

120

1.62

0.94

1.6

2.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

284

1.43

0.87

4.4

3.2

—

(3018095) Leukocytes [#/volume] in Urine

267

1.43

0.84

6.2

3.4

39.86

139.70

e6/l

0.46

181

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

277

1.42

0.83

1.9

110.66

96.96

pmol/l

0.45

137

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.75

0.83

1.5

2.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

133

1.54

0.82

3.3

2.3

0.71

0.75

e6/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.87

0.80

2.5

2.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.87

0.80

3.2

5.8

22.55

25.14

mmol/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

735

1.56

0.80

4.3

4.0

5.65

5.81

mmol/l

0.51

681

(3035350) Ketones [Presence] in Urine by Test strip

375

1.38

0.78

4.4

3.2

0.00

estimate

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.81

0.77

1.3

1.1

—

(1002224) Polysomnography panel

1.81

0.77

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.91

0.75

1.1

1.6

—

(3019060) Gas panel - Arterial blood

1.76

0.71

1.1

4.1

—

(3025941) Bacteria identified in Stool by Culture

1.68

0.68

1.3

1.2

—

(3000494) Fungus identified in Specimen by Culture

1.59

0.66

1.4

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.59

0.66

2.7

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

354

1.33

0.65

3.0

2.7

117.00

90.35

ug/l

0.63

325

(3000492) Spirometry study

1.62

0.65

1.3

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

287

1.35

0.65

13.8

13.4

1.13

1.21

inr

—

(3007164) IgA [Mass/volume] in Serum or Plasma

185

1.40

0.65

1.5

1.4

2.49

2.31

g/l

0.19

112

(3028707) Methadone [Presence] in Urine by Screen method

1.76

0.64

3.4

1.7

—

(3022145) Colonoscopy Study observation

1.57

0.63

1.2

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1.70

0.62

1.2

3.4

51.70

47.68

—

(3044889) 12 lead EKG panel

478

1.30

0.57

4.4

3.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

179

0.68

0.57

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

126

1.43

0.56

4.0

3.9

23.04

20.11

—

(36304419) Bacteria [Presence] in Urine

199

1.35

0.56

4.8

2.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

209

1.34

0.54

4.7

3.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1.57

0.54

5.7

3.6

123.67

133.00

g/l

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

698

1.35

0.52

6.4

4.7

1.87

1.85

mu/l

0.05

647

(3024731) MCV [Entitic volume]

885

0.70

0.52

23.7

18.5

90.55

90.31

0.20

872

(3035941) MCH [Entitic mass]

885

0.70

0.52

23.7

18.4

30.36

30.20

0.47

872

(3010813) Leukocytes [#/volume] in Blood

885

0.70

0.52

23.8

18.5

6.74

6.63

e9/l

0.23

865

(3000963) Hemoglobin [Mass/volume] in Blood

885

0.70

0.52

24.0

18.6

138.51

136.99

g/l

0.48

872

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.55

0.52

2.3

3.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

174

1.34

0.51

3.4

2.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.48

0.48

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

204

1.31

0.47

2.1

1.6

—

(3013512) EKG study

195

1.31

0.47

2.9

3.7

—

(40768804) Tissue Pathology biopsy report

291

1.26

0.45

2.3

1.9

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1.54

0.42

1.0

3.8

25.74

24.81

mmol/l

—

(3007461) Platelets [#/volume] in Blood

884

0.71

0.40

23.7

18.6

257.45

252.55

e9/l

0.34

865

(3009542) Hematocrit [Volume Fraction] of Blood

884

0.71

0.40

23.5

18.6

41.37

40.90

0.50

842

(36660697) Celiac disease serology panel - Serum

1.43

0.38

1.3

1.2

—

(3002256) Pathology report gross observation

1.40

0.38

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

605

1.24

0.38

3.8

3.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

732

1.27

0.35

3.6

3.5

1.37

1.25

mmol/l

0.85

681

(3002385) Erythrocyte distribution width [Ratio]

690

1.25

0.35

21.9

15.6

14.59

14.43

0.08

682

(3029937) Albumin [Presence] in Urine by Test strip

194

1.24

0.34

5.7

3.1

0.00

estimate

—

(3017732) Neutrophils [#/volume] in Blood

1.32

0.31

1.4

2.4

4.29

4.15

e9/l

—

(4035726) Immunohistochemistry procedure

1.27

0.30

1.4

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

116

0.75

0.29

1.9

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.35

0.29

1.9

1.8

—

(3019225) pH of Specimen

1.29

0.28

3.4

4.8

—

(3022948) Iron [Moles/volume] in Serum or Plasma

113

1.28

0.28

3.2

2.3

15.56

14.33

umol/l

0.36

105

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

170

0.79

0.28

2.4

2.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

0.69

0.27

1.4

3.3

1.32

1.73

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

0.70

0.25

1.3

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

343

0.86

0.24

2.7

2.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

700

1.19

0.23

5.0

4.8

38.13

39.12

mmol/mol

0.33

660

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

784

1.23

0.23

4.4

4.2

2.93

2.85

mmol/l

0.33

726

(3020682) Albumin/Creatinine [Ratio] in Urine

186

0.83

0.21

5.8

4.0

3.42

14.85

mg/mmol

—

127

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

0.21

0.0

1.2

—

614.18

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.46

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(21494755) Public health laboratory ask at order entry panel

113

0.78

0.21

1.0

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.21

0.0

1.1

—

(4146454) Self-monitoring of blood glucose

0.00

0.21

0.0

3.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.21

0.0

3.2

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.21

0.0

3.2

—

3.95

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

0.21

0.0

1.4

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

2.4

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.21

0.0

3.2

—

106.00

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.24

0.21

1.5

2.1

—

(40761511) CBC panel - Blood by Automated count

828

1.25

0.20

11.5

11.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.0

—

4.43

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1.19

0.20

1.3

1.9

1.43

4.77

ug/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

797

1.21

0.19

18.5

12.6

16.27

21.88

mg/l

1.50

607

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

582

1.13

0.19

2.9

31.91

42.70

u/l

1.76

552

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.71

0.17

1.2

1.6

—

(3012516) Albumin [Mass/volume] in Urine

172

0.85

0.17

4.7

3.5

11.81

80.90

mg/l

—

119

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

111

1.20

0.17

1.7

1.9

—

(3026008) Bacteria identified in Urine by Culture

208

1.14

0.16

5.0

2.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

838

0.84

0.15

11.7

9.6

28.34

26.82

u/l

0.33

812

(46235355) HIV 1 and 2 tests - Meaningful Use set

211

0.88

0.15

2.2

2.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

825

1.16

0.11

18.1

13.7

79.67

74.58

umol/l

0.37

825

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.16

0.11

1.4

1.7

—

(3009343) pH of Capillary blood

1.14

0.10

3.4

2.9

—

7.45

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.07

0.09

1.8

1.3

—

(1761868) Lipid panel - Serum or Plasma

293

1.09

0.09

2.7

2.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.04

0.09

2.4

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.04

0.09

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.04

0.09

1.0

1.3

—

(40761535) Cells panel - Urine sediment

1.14

0.09

2.3

3.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

146

1.12

0.09

1.2

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

225

1.09

0.08

2.2

2.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

133

0.89

0.08

1.5

—

(40761536) Microorganisms panel - Urine sediment

1.07

0.08

4.3

3.2

—

(3042936) Bacteria identified in Isolate by Culture

109

1.12

0.06

3.4

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

768

1.09

0.06

4.1

3.9

1.35

1.45

mmol/l

1.55

715

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

772

1.06

0.02

4.1

3.9

4.76

4.73

mmol/l

0.12

722

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

127

0.94

0.02

1.2

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

733

1.04

0.01

13.7

11.5

89.83

87.90

ml/min/173m2

0.28

596

(40768797) Stomach Pathology biopsy report

1.07

0.01

1.3

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

768

1.01

0.00

18.4

13.4

139.52

139.74

mmol/l

0.34

748

(3003694) ABO and Rh group [Type] in Blood

225

0.97

0.00

1.6

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

769

1.01

0.00

18.4

13.5

3.98

3.93

mmol/l

0.80

748

(21494434) Karyotype in Bone marrow

0.00

0.0

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.2

—

(3008898) HLA-B27 [Presence]

0.94

0.00

1.0

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3047189) Immunofixation for 24 hour Urine

0.00

0.0

2.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

0.00

0.0

4.4

—

68.60

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

4.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

159.64

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

1.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

0.0

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.5

—

25.74

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.0

2.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.0

1.9

—

8.44

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.0

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.0

1.0

—

(3000012) Reticulocyte production index

0.00

0.0

2.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

0.98

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

109.94

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

124.43

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

31.13

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

1.72

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

2.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

5.0

—

25.41

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

-0.00

0.0

1.0

—

(3045142) Bone marrow Pathology biopsy report

0.00

-0.00

0.0

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.0

—

164.83

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.90

-0.00

3.3

5.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

2.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_EFFEC_OTHER_DEPRI – Effects of other deprivation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Effects of other deprivation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Effects of other deprivation (ST19_EFFEC_OTHER_DEPRI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints